Skip to main content
CHUGAI PHARMACEUTICAL CO., LTD. logo

CHUGAI PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 4519 ISIN · JP3519400000 LEI · 529900T9LAII161DCN95 T Manufacturing
Open in API
Filings indexed 81 across all filing types
Latest filing 2017-03-23 Annual Report
Country JP Japan
Listing T 4519

About CHUGAI PHARMACEUTICAL CO., LTD.

https://www.chugai-pharm.co.jp/english/

Chugai Pharmaceutical Co., Ltd. is a research and development-driven pharmaceutical company dedicated to creating innovative medical products to address unmet medical needs. As a member of the Roche Group, Chugai leverages its advanced expertise in biotechnology and science to develop novel treatments, establishing a leading position in therapeutic antibodies. The company's strategy emphasizes a shift towards discovery research and early clinical development, the integration of digital technologies, and open innovation through external partnerships. Its core therapeutic areas include oncology, rheumatology, and haemophilia, where it provides biopharmaceuticals and molecular targeted therapies to patients.

Recent filings

Filing Released Lang Actions
有価証券報告書－第106期(2016/01/01－2016/12/31)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard Japanese regulatory filing equivalent to the US 10-K. It contains comprehensive financial statements, management discussion, and corporate information for the fiscal year 2016. It is a full annual report, not an announcement or a summary. FY 2016
2017-03-23 Japanese
四半期報告書－第106期第3四半期(2016/07/01－2016/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (第３四半期報告書) filed by Chugai Pharmaceutical Co., Ltd. with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains comprehensive financial statements, including the Consolidated Statement of Profit or Loss and Comprehensive Income for the third quarter of 2016. It is a formal regulatory filing containing substantive financial data, not an announcement or a certification, thus fitting the definition of an Interim/Quarterly Report. 9M 2016
2016-10-31 Japanese
四半期報告書－第106期第2四半期(2016/04/01－2016/06/30)
Interim / Quarterly Report
2016-07-29 Japanese
四半期報告書－第106期第1四半期(2016/01/01－2016/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Chugai Pharmaceutical Co., Ltd. for the first quarter of 2016. It contains detailed financial statements, including the Consolidated Statement of Profit or Loss, Statement of Comprehensive Income, and Statement of Financial Position, as well as management's analysis of financial results. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2016
2016-04-28 Japanese
有価証券報告書－第105期(2015/01/01－2015/12/31)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K. It contains comprehensive financial statements, management discussion, and corporate information for the fiscal year ending December 31, 2015. It is a formal regulatory filing submitted to the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. FY 2015
2016-03-24 Japanese
四半期報告書－第105期第3四半期(2015/07/01－2015/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (第３四半期報告書) filed by Chugai Pharmaceutical Co., Ltd. in accordance with the Financial Instruments and Exchange Act of Japan. It contains detailed financial statements, including the Consolidated Statement of Income and Comprehensive Income for the third quarter of 2015. Since it provides substantive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. 9M 2015
2015-10-30 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.